Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 22 von 201

Details

Autor(en) / Beteiligte
Titel
Severe Pulmonary Disease Associated with Electronic-Cigarette–Product Use — Interim Guidance
Ist Teil von
  • MMWR. Morbidity and mortality weekly report, 2019-09, Vol.68 (36), p.787-790
Ort / Verlag
United States: Centers for Disease Control & Prevention (CDC)
Erscheinungsjahr
2019
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • On September 6, 2019, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). As of August 27, 2019, 215 possible cases of severe pulmonary disease associated with the use of electronic cigarette (e-cigarette) products (e.g., devices, liquids, refill pods, and cartridges) had been reported to CDC by 25 state health departments. E-cigarettes are devices that produce an aerosol by heating a liquid containing various chemicals, including nicotine, flavorings, and other additives (e.g., propellants, solvents, and oils). Users inhale the aerosol, including any additives, into their lungs. Aerosols produced by e-cigarettes can contain harmful or potentially harmful substances, including heavy metals such as lead, volatile organic compounds, ultrafine particles, cancer-causing chemicals, or other agents such as chemicals used for cleaning the device (1). E-cigarettes also can be used to deliver tetrahydrocannabinol (THC), the principal psychoactive component of cannabis, or other drugs; for example, "dabbing" involves superheating substances that contain high concentrations of THC and other plant compounds (e.g., cannabidiol) with the intent of inhaling the aerosol. E-cigarette users could potentially add other substances to the devices. This report summarizes available information and provides interim case definitions and guidance for reporting possible cases of severe pulmonary disease. The guidance in this report reflects data available as of September 6, 2019; guidance will be updated as additional information becomes available.
Sprache
Englisch
Identifikatoren
ISSN: 0149-2195
eISSN: 1545-861X
DOI: 10.15585/mmwr.mm6836e2
Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6755818

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX